Pharma Co. Inks $22M Deal Ending Opioid Reporting Claims
The country's largest privately owned pharmaceutical distributor will pay the federal government $22 million to settle claims that it failed to report suspicious orders of opioid medications, Louisiana prosecutors announced Friday....To view the full article, register now.
Already a subscriber? Click here to view full article